IPAM

Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Cultures of Microorganisms for medical purposes; Biotechnological preparations in the nature of enzymes for medical purposes; Stem cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes

Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Research and development of technology for medicinal chemical manufacturing; scientific research in the nature of evaluating clinical trials

Medical and health assessment services relating to DNA, genetics and genetic testing; Genetic testing for medical treatment purposes; Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical diagnostic testing, monitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes